• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Ophtec Announces Modern New Brand Identity: Keeping Up with the Times

Article

Celebrating 40-year anniversary with new brand/new products.

(Image Credit: AdobeStock/Blue Planet Studio)

(Image Credit: AdobeStock/Blue Planet Studio)

Ophtec, the Dutch manufacturer of intraocular lenses (IOLs) based in Groningen, is hitting the 40-year mark in 2023. To celebrate the event, the company is launching a new brand identity that is modernized and fit for the future, according to the company’s press release.

Marketing manager Remko Bos explains the reasons behind the rebranding, “Ophtec always had a full focus on making unique products. Our people are highly dedicated to support ophthalmologists to do their best job possible. Our branding was somehow underexposed. This year is a great moment for us to honor our heritage, fresh up our brand and connect to a new generation of eye-doctors.”

Bos describes the new brand as “quite a transformation,” with colors that catch the eye.

“New look, same focus, and an ingenious partner to ophthalmologists. Together, we help people to see clearly," said Bos.

Ophtec was founded in 1983 by Prof. Dr. Jan Worst, who invented the Artisan lens, the first iris-fixated IOL. To this day, the company remains family-owned.

“When my parents established Ophtec in 1983, it was their ambition to let surgeons and patients benefit from better products than were commonly available at the time,” Chief Executive Officer Erik Jan Worst commented. “And 40 years later we are still here. This makes me deeply proud and energized to lead the company into the future.”

The rebranding, which will become official on March 10, 2023, will be followed by the introduction of new products.

Worst announced the launch of ArtiPlus, a new iris-fixated presbyopia correction phakic IOL, in South Korea. A clinical study of the IOL is underway in Europe, and he described the results as “spectacular.”

Ophtec is also introducing a new pre-loaded injector system for the Precizon cataract lenses and after the summer the company expects to launch an exciting new lens concept.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
William F. Wiley, MD, shares some key takeaways from his ASCRS presentation on binocularity and aperture optics.
© 2024 MJH Life Sciences

All rights reserved.